top | item 39362401

(no title)

patientzero | 2 years ago

If the goal is early diagnosis and the separate detections aren't getting confounded, why does it matter what parallel chain of causation leads to Parkinson in the patient and a correlating reading in the nose or other test?

If no one in a normal state has the same mix of fear, anger and confusion and this leads to a microbial change around sweat glands, then that is a valid test of greater accuracy than many existing medical tests.

discuss

order

BurningFrog|2 years ago

In the tests, she's presumably smelling people known to have the disease or not, and maybe she can pick up on that knowledge through subtle social cues.

Impressive in itself, but that's useless for diagnosing people who don't know they have a disease, which would be the medical breakthrough.

shermantanktop|2 years ago

No presuming necessary. In the article, it describes a test involving smelling t-shirts in boxes.

keltor|2 years ago

She was able to detect a person who they thought was a false positive and turned out several months later did have Parkinson's. She detected her husbands before he had signs as well.

They also found the molecule she was smelling which was expressed with sebum. This isn't entirely unfounded as they already knew about dogs smelling cancers and other various diseases.

cogman10|2 years ago

But what if, for example, she's just sensitive to the smell of fecal matter and these people tend to have loser poops? Now is she detecting parkinson or is she detecting IBS or someone that ate something spicy or drank milk while being lactose intolerant.

The issue is the one of the false positive and bayesian statistics. If she's detecting something that has a bunch of common causes then it's not really helpful to run a suite of tests to find an underlying problem on everyone that smells the same.

A fever can be a sign of cancer, but it's also a sign of the flu. Should we check everyone with a fever for cancer?

jondea|2 years ago

I'm not an expert, but a very quick search showed a meta analysis[1] which considers the false positives of using volatile biomarkers as a diagnosis. The original paper[2], of which Joy is co-author has a much smaller sample size, but also has a control group to measure false positives.

Again, I'm not an expert, but from personal experience I know that Parkinson's can be hard to diagnose definitively until there are serious symptoms. This test may be relatively poor but still be useful as a piece of evidence.

[1]: https://www.sciencedirect.com/science/article/abs/pii/S03038...

[2]: https://pubs.acs.org/doi/full/10.1021/acscentsci.8b00879